The 2016 WHO classification recognizes and categorizes high‐grade B‐cell lymphomas (HGBCL) with MYC and BCL2 and/or BCL6 gene rearrangements as a separate entity, commonly referred to as “double‐hit” lymphomas. This evidence concerns the gene BCL2 and B-cell non-Hodgkin lymphoma.